SNDX FY 2015 Earnings — Syndax Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

SNDXSyndax Pharmaceuticals, Inc.

$2B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$627,000

Gross Profit

$627,000100.0% margin

Operating Income

-$21M-3271.6% margin

Net Income

-$24M-3846.7% margin

EPS (Diluted)

$-4.31

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$90M

Total Liabilities

$23M

Stockholders' Equity

$67M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$627,000	$0	—
Gross Profit	$627,000	$0	—
Operating Income	-$21M	-$21M	+3.8%
Net Income	-$24M	-$20M	-21.6%